{
    "id": 26898,
    "fullName": "TP53 S215G",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "TP53 S215G lies within the DNA-binding domain of the Tp53 protein (PMID: 15510160). S215G results in decreased Tp53 transactivation activity and leads to reduced apoptosis relative to wild type Tp53 in cell culture (PMID: 22862161).",
            "references": [
                {
                    "id": 609,
                    "pubMedId": 22862161,
                    "title": "Roscovitine-induced apoptosis of H1299 cells depends on functional status of p53.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22862161"
                },
                {
                    "id": 5145,
                    "pubMedId": 15510160,
                    "title": "Post-translational modification of p53 in tumorigenesis.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15510160"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7157,
        "geneSymbol": "TP53",
        "terms": [
            "TP53",
            "BCC7",
            "BMFS5",
            "LFS1",
            "P53",
            "TRP53"
        ]
    },
    "variant": "S215G",
    "createDate": "08/22/2017",
    "updateDate": "08/22/2017",
    "referenceTranscriptCoordinates": {
        "id": 95626,
        "transcript": "NM_000546",
        "gDna": "chr17:g.7674888T>C",
        "cDna": "c.643A>G",
        "protein": "p.S215G",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11744,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, non-small cell lung carcinoma cells overexpressing TP53 S215G were resistant to Roscovotine (seliciclib) induced apoptosis in culture (PMID: 22862161).",
            "molecularProfile": {
                "id": 28223,
                "profileName": "TP53 S215G"
            },
            "therapy": {
                "id": 1129,
                "therapyName": "Seliciclib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 609,
                    "pubMedId": 22862161,
                    "title": "Roscovitine-induced apoptosis of H1299 cells depends on functional status of p53.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22862161"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11784,
            "approvalStatus": "Phase II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, Paraplatin (carboplatin) and Adavosertib (MK-1775) combination treatment resulted in disease progression in an ovarian cancer patient harboring TP53 P98fs, R175C, and S215G (PMID: 27998224).",
            "molecularProfile": {
                "id": 28235,
                "profileName": "TP53 P98fs TP53 R175C TP53 S215G"
            },
            "therapy": {
                "id": 1194,
                "therapyName": "Adavosertib + Carboplatin",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 9762,
                    "pubMedId": 27998224,
                    "title": "Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27998224"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28223,
            "profileName": "TP53 S215G",
            "profileTreatmentApproaches": [
                {
                    "id": 14689,
                    "name": "p53 Activator",
                    "profileName": "TP53 S215G"
                },
                {
                    "id": 14690,
                    "name": "p53 Gene Therapy",
                    "profileName": "TP53 S215G"
                }
            ]
        },
        {
            "id": 28235,
            "profileName": "TP53 P98fs TP53 R175C TP53 S215G",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 95627,
            "transcript": "NM_001126113",
            "gDna": "chr17:g.7674888T>C",
            "cDna": "c.643A>G",
            "protein": "p.S215G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95628,
            "transcript": "NM_001126114",
            "gDna": "chr17:g.7674888T>C",
            "cDna": "c.643A>G",
            "protein": "p.S215G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95626,
            "transcript": "NM_000546",
            "gDna": "chr17:g.7674888T>C",
            "cDna": "c.643A>G",
            "protein": "p.S215G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95625,
            "transcript": "NM_001126112",
            "gDna": "chr17:g.7674888T>C",
            "cDna": "c.643A>G",
            "protein": "p.S215G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}